Coordinated health coaching is associated with improved diabetes outcomes with lower cost vs. traditional diabetes management. Diabetes Health Partnership (DHP) is a telephonic coaching program designed to empower individuals with diabetes. This 12-month, observational, self-controlled multi-site study combined retrospective (6 mth pre-baseline) and prospective (6 mth post-baseline) data to assess the impact of the DHP program on A1C among 57 individuals with type 1 and type 2 diabetes. Mean change from baseline A1C (8.4±1.1%) was significant (-0.5 ± 0.9%, <0.0001) within the full cohort (n=54) but notable differences in A1C between Responders (n=27, ≥0.5% reduction) vs. Non-Responders (n=27, <0.5% reduction) were observed (Figure 1), with comparable medication changes with the exception of insulin. Differences in A1C between Responders and Non-Responders may be explained by a combination of differences in baseline A1C (8.5 ± 0.8% vs. 8.3 ± 1.2%), baseline body weight (191.2 ± 36.6 lbs vs. 201 ± 42.9 lbs) and change in body weight (-5.0 ± 10.1 lbs vs. 0.6 ± 6.7 lbs). Notably more Responders than Non-Responders had >3 coaching sessions focused on diet/nutrition (9 vs. 3, respectively). Participation in the DHP program was associated with clinically-significant improvements in glycemic control in many individuals with suboptimally controlled diabetes.
W.C. Biggs: Consultant; Self; Roche Diabetes Care. Research Support; Self; Dexcom, Inc., Gan & Lee Pharmaceuticals, Mylan, Novo Nordisk A/S, Sanofi US. A. Buskirk: Employee; Self; Roche Diabetes Care. L. Borsa: None. M.R. Lyden: None. C. Parkin: Consultant; Self; Abbott, CeQur Corporation, Dexcom, Inc., DreaMed Diabetes, Novo Nordisk Inc., Onduo, Roche Diabetes Care, Valeritas, Inc. B. Petersen: Employee; Self; Roche Diabetes Care.
